Zdrowie i gospodarka · 7.08.2024
Enhancing Diversity in Therapeutics Development for Pediatric Patients; Public Workshop
The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled "Enhancing Diversity in Therapeutics Development for Pediatric Patients." The aim of the public workshop is to explore strategies to increase the enrollment of historically underrepresented populations in pediatric clinical trials and to help improve the strength and generalizability of the evidence for the intended use population.